Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
China · Delayed Price · Currency is CNY 5.26
+0.05 (0.96%)
May 26, 2026, 3:04 PM CST
SHE:002252 Revenue
Shanghai RAAS Blood Products had revenue of 1.51B CNY in the quarter ending March 31, 2026, a decrease of -24.75%. This brings the company's revenue in the last twelve months to 6.85B, down -15.68% year-over-year. In the year 2025, Shanghai RAAS Blood Products had annual revenue of 7.35B, down -10.13%.
Revenue (ttm)
6.85B
Revenue Growth
-15.68%
P/S Ratio
4.99
Revenue / Employee
1.69M
Employees
4,045
Market Cap
34.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.35B | -828.28M | -10.13% |
| Dec 31, 2024 | 8.18B | 212.50M | 2.67% |
| Dec 31, 2023 | 7.96B | 1.40B | 21.27% |
| Dec 31, 2022 | 6.57B | 2.28B | 53.16% |
| Dec 31, 2021 | 4.29B | 1.53B | 55.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Revenue RankingsShanghai RAAS Blood Products News
- 27 days ago - Shanghai RAAS Blood Products Quarterly report: Q1 2026 - Filings
- 2 months ago - Shanghai RAAS Blood Products Annual report: Q4 2025 - Filings
- 7 months ago - Shanghai RAAS Blood Products Quarterly report: Q3 2025 - Filings
- 9 months ago - Shanghai RAAS Blood Products Quarterly report: Q2 2025 - Filings